Caremark Rx — Merger or Acquisition (November 2006)
15 slides from Caremark Rx's merger presentation, Nov 15, 2006
Slide 1: Creating the Premier Pharmacy Services Provider
1 Howard McLure Senior Executive Vice President & COO Credit Suisse Healthcare Conference November 16, 2006 Creating the Premier Pharmacy Services Provider Filed by Caremark Rx, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and Deemed Filed pursuant to Rule 14a-12 of the Securities Exch
Slide 2: Forward-looking statements
2 This document contains certain forward-looking statements about CVS and Caremark. When used in this document, the words “anticipates”, “may”, “can”, “believes”, “expects”, “projects”, “intends”, “likely”, “will”, “to be” and any similar expressions and any other statements that are not historical
Slide 3: CVS/Caremark Merger Overview
3 Stock-for-stock merger of equals CVS will issue 1.67 shares for each CMX share Management team: Mac Crawford – Chairman Tom Ryan – President and CEO Dave Rickard – CFO Howard McLure – President of PBM Board Composition: 50/50 split Corporate HQ: Woonsocket, RI PBM HQ: Nashville, TN Expected closin
Slide 4: Changing U.S. Healthcare Landscape
4 U.S. drug spend projected to continue to grow Aging population driving higher drug utilization Increased diagnosis and treatment of chronic disease Increased use of high cost specialty drugs Lack of adherence to therapy is costly Payers asking consumers to make more decisions Medicare Part D Consu
Slide 5: Merger Creates Premier Pharmacy Services Provider
5 Brings Caremark’s capabilities closer to the consumer Creates platform to deliver innovative new services Expected to yield better outcomes More effective cost management for payers Differentiated services for consumers and payers Greater choice and convenience for consumers Expected to accelerate
Slide 6: Caremark Strengths & Capabilities
6 Experienced management team Integrated pharmacy services PBM Specialty Disease Management Analytics and Outcomes Connectivity Attractive, balanced customer mix Fortune 1000 employers Health plans Medicare Part D Financials Highest EBITDA/Adj Rx Strong cash flow & balance sheet Caremark Strengths &
Slide 7: Caremark Q3 2006 Results
7 Expect 2006 EPS of $2.40 to 2.41*, +22% *Guidance range excludes gain from settlement and treasury-lock +31% $0.67 Diluted EPS** $855 M YTD Cash Flow from Ops +21% $3.19 EBITDA / Adjusted Rx +13% $9.1 B Revenue ** Q3 EPS includes $0.02 per share gain on treasury-lock Slide contains Non-GAAP financ
Slide 8: CVS Strengths & Capabilities
8 #1 drugstore chain in America Largest retail base - 6,200 stores Leading presence in over 70% of Top 100 U.S. regions Growing pharmacy business Acquisition upside revenue, shrink, operating margin MinuteClinic largest U.S. provider of retail-based health care Strong front store business ExtraCare,
Slide 9: Value for Employers & Health Plans
9 Bringing Caremark programs & capabilities closer to the consumer will… Enable participants & payers to make better decisions Pharmacist will be able to discuss plan design alternatives Economics of mail vs. retail dispensing will be clear Provides participants with more choice and access Enable mo
Slide 10: Value for Employers & Health Plans
10 Combining Caremark and CVS capabilities will… Allow CVS/Caremark to offer differentiated services Access to in-store or client-site MinuteClinics Health assessments for participants Real-time compliance & persistency programs In-store consultation for injectable therapies Enhance Specialty busine
Slide 11: Benefits to Consumers
11 Choice Access to information about their plan designs at the pharmacy counter will enable consumers to make cost-effective decisions Services Pharmacist can help maximize benefits Pharmacist can better monitor patient safety Improved compliance and outcomes Access to MinuteClinics Convenience Pha
Slide 12: Benefits to Consumers
12 Services Pharmacist can help maximize benefits Help choose the right branded medication Highlight generic alternatives Offer OTC step therapies Consultation by phone or at local CVS store Pharmacist can better monitor patient safety CVS will now have full view of patient Rx history Improved compl
Slide 13: Benefits to Shareholders
13 Approximately $400 million in annual synergies Purchasing Overhead Exit 2008 at annualized rate of over $400 million in synergies Accretive first full year after close Significant free cash flow generation Platform to develop new / differentiated services Benefits to Shareholders
Slide 14: Additional information about the proxy statement/prospectus
14 Caremark and CVS will file a joint proxy statement/prospectus with the SEC in connection with the proposed merger. Caremark and CVS urge investors and stockholders to read the joint proxy statement/prospectus when it becomes available and any other relevant documents filed by either party with th
Slide 15: Howard McLure, Credit Suisse Healthcare Conference
15 Howard McLure Senior Executive Vice President & COO Credit Suisse Healthcare Conference November 16, 2006 Creating the Premier Pharmacy Services Provider